A carregar...
Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
The third-generation aromatase inhibitors (AIs), letrozole, anastrozole and exemestane, are becoming the first choice endocrine drugs for post-menopausal women with breast cancer, since they present greater efficacy when compared with tamoxifen in both adjuvant and metastatic setting. In particular,...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2682397/ https://ncbi.nlm.nih.gov/pubmed/19281057 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|